bioRxiv ScienceSearch

bioRxiv · 10.1101/2020.05.09.085829

What is so special about Giardia ventral flagella? Interspecies cross-reacting monoclonal antibody against Pneumocystis jiroveci reacts with cilia and sparks questions on host-pathogen interactions

Abstract

A mouse monoclonal antibody (Moab 4B8) cross-reacting with cilia/flagella was obtained by immunization with Pneumocystis-infected human lung tissue. A key observation was that Moab 4B8 reacted with the ventral flagella of Giardia intestinalis, but not with the three other flagellar pairs of this protozoan. To further identify the 4B8 target, its distribution was studied by immunofluorescence staining of cells and tissues of various origin. The target epitope recognized by Moab 4B8 was found to be associated with structures rich in microtubules; e.g. the mitotic spindle of cultured cells, ciliated airway epithelia, Sertoli cells of the testis and ependymal cells lining brain ventricles. The conserved nature of the 4B8 target was further shown by its presence in cilia of metazoan Schistosome larva and the green alga Chlamydomonas reinhardtii. Absence of the 4B8 target from Trypanosomes and Leishmania flagella suggested that it is involved in some function not primarily related to motility. Its presence in only the ventral flagella of Giardia therefore provides a unique opportunity to elucidate the relationship between ciliary structure and function in the same organism. The observed locations of the 4B8 target in tissues and cells of various origin, suggest a similarity to annexins - and specifically to -19-giardin. This raises the possibility that it is involved in intra-flagellar transport and provides a basis for further studies aiming at its identification. Author SummaryPneumocystis is a ubiquitous fungal organism apparently colonizing the lung at an early age to cause pneumonia only in individuals with an impaired immune system. In the alveolar spaces of such individuals, extensive and frequently fatal proliferation of the pathogen occurs. Pneumocystis has no known reservoir in nature and apparently is transmitted directly from infected individuals via an airborne route. Adaptation of this Ascomycotic fungus to a parasitic lifestyle during its evolution apparently resulted in dependence upon host nutrients, but little is known about this presumed adaptation process. In this report, a previously unrecognized constituent of human Pneumocystis is detected using a monoclonal anti-Pneumocystis jiroveci antibody (Moab 4B8) which was obtained as a by-product in the search for reagents useful in diagnostics. The Moab 4B8 was shown to react with Pneumocystis but also with cytoskeletal microtubules, e.g. in ciliated epithelia, but not ubiquitously a constituent of the conserved cilia/flagella axonemal structure. A striking example of the discriminating capacity of antibody 4B8 was seen in immunofluorescent staining of the protozoan Giardia intestinalis, where only one out of four flagellar pairs expresses the target epitope. This observation of flagellar heterogenicity provoked the question raised in the title of this report. It also provides the basis for the discussion, which arrives at suggestive evidence for the involvement of the described evolutionarily conserved target in host-pathogen interactions related to membrane transport.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Linder, E.. 2020-05-10. What is so special about Giardia ventral flagella? Interspecies cross-reacting monoclonal antibody against Pneumocystis jiroveci reacts with cilia and sparks questions on host-pathogen interactions. https://doi.org/10.1101/2020.05.09.085829

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology